Arcadia Biosciences and Ardent Mills Announce Collaboration to Develop and Commercialize Wheat Innovations

— Initial project focuses on extending shelf life of whole wheat
and promoting whole grain consumption —

DENVER & DAVIS, Calif.–(BUSINESS WIRE)–Arcadia
Biosciences, Inc. (Nasdaq: RKDA), an agricultural food ingredient
company, and Ardent
Mills, LLC, North America’s leading flour-milling and ingredient
company, today announced a collaboration to develop and commercialize
innovative wheat varieties. The first project focuses on extending the
shelf life and improving the flavor of whole wheat products.

“For several years, we have been investing in this strategy. We see this
trait as a big and important step forward that will benefit bakers, food
manufacturers, the food service industry, and ultimately consumers,”
stated Ardent Mills CEO Dan Dye.

Using patented Arcadia trait technology, the storage life of whole wheat
flour can be extended by slowing the enzymatic processes that reduce
shelf life. Because milled flour from wheat carrying Arcadia’s trait
technology oxidizes more slowly, it also minimizes the bitterness
associated with most whole wheat products. This trait is expected to
help improve the taste of whole wheat products and help reduce waste.

The Extended Shelf Life wheat trait was developed using Arcadia’s
proprietary non-GM wheat genetic diversity library, an extensive and
exclusive resource of trait lines with high-density variations in
genetic composition and gene function. Because it is non-GM, the trait
has wide application potential across both conventional and organic
farming practices. The company recently received a U.S. patent for the
technology, the latest in Arcadia’s portfolio of wheat trait
improvements.

“This new trait was developed through traditional breeding. While
innovative thinking has brought it this far, further collaboration will
continue between Ardent Mills, Arcadia and university partners to bring
this trait to commercial reality,” said Shrene White, General Manager,
The Annex by Ardent Mills.

“As the leading flour supplier and grain innovator in North America,
Ardent Mills is the ideal partner to bring this technology to the
market,” said Raj Ketkar, president and CEO of Arcadia. “Wheat is an
important source of fiber, protein, nutrients and minerals for consumers
throughout the world, and these creative approaches to improving the
functional properties of wheat can have a significant impact on the
future of whole grain consumption.”

About Ardent Mills, LLC

Ardent Mills is the premier flour-milling and ingredient company whose
vision is to be the trusted partner in nurturing its customers,
consumers and communities through innovative and nutritious grain-based
solutions. Ardent Mills’ operations and services are supported by more
than 40 flour mills and bakery-mix facilities along with a specialty
bakery, Ardent Mills Innovation Center and Mobile Innovation Center, all
located in the U.S., Canada and Puerto Rico. Deeply rooted in
communities throughout North America, Ardent Mills is headquartered in
Denver, Colorado and employs more than 100 certified millers, supporting
thousands of local jobs and contributing billions of dollars to local
economies. To learn more about Ardent Mills, visit ardentmills.com.

About Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc. (Nasdaq: RKDA) develops and markets high-value
food ingredients and nutritional oils that help meet consumer demand for
a healthier diet. Arcadia’s GoodWheat™ branded ingredients deliver
health benefits to consumers and enable consumer packaged goods
companies to differentiate their brands in the marketplace. The
company’s agricultural traits are being developed to enable farmers
around the world to be more productive and minimize the impact of
agriculture on the environment. For more information, visit www.arcadiabio.com.

Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are subject to risks and uncertainties that
could cause actual results to differ materially, and reported results
should not be considered as an indication of future performance. These
risks and uncertainties include, but are not limited to: Arcadia’s and
its partners’ and affiliates’ ability to develop commercial products
incorporating their traits, and complete the regulatory review process
for such products; Arcadia’s compliance with laws and regulations that
impact Arcadia’s business, and changes to such laws and regulations;
Arcadia’s future capital requirements and ability to satisfy its capital
needs; Arcadia’s ability to develop, enforce and defend its intellectual
property rights; and the other risks set forth in Arcadia’s filings with
the Securities and Exchange Commission from time to time, including the
risks set forth in Arcadia’s Annual Report on Form 10-K for the year
ended December 31, 2017 and other filings. These forward-looking
statements speak only as of the date hereof, and Arcadia Biosciences,
Inc. disclaims any obligation to update these forward-looking statements.

Contacts

Arcadia Biosciences
Jeff Bergau
+1-312-217-0419
jeff.bergau@arcadiabio.com
or
Ardent
Mills
Mary Ann Strombitski
+1-719-271-5295
maryann.strombitski@ardentmills.com